Aurobindo Pharma has received final approval from the US FDA to manufacture and market Levonorgestrel tablets in 1.5 mg strength. The product had an estimated market size of $64 million for the 12 months ended October 2015 according to IMS, Aurobindo Pharma said.
The company’s shares are likely to see buying interest from traders, though analysts will closely watch the development. Aurobindo Pharma currently has a total of 221 ANDA approvals.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.